secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2026-09-22T20:43:38+00:00
Accession:  0000920148-26-000205
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp reaffirms 2026-29 outlook and flags CMS PAMA rate cuts
--------------------------------------------------------------

- CMS released preliminary Clinical Laboratory Fee Schedule rates for 2027-2029 under PAMA on Sept 21, 2026.
- Labcorp says rates are based on non-representative data and would impose steep annual payment cuts threatening patient access.
- Reaffirms 2026-29 outlook: 5-8% CAGR revenue, 75-150 bps adjusted operating margin expansion by end of 2029.
- Reaffirms 8.5-11.5% CAGR adjusted EPS growth and free cash flow growth in line with adjusted earnings.
- Expects to provide 2027 guidance impact in February 2027; continues to support bipartisan RESULTS Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000205/0000920148-26-000205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000205/lh-20260922.htm
  HTML page:      https://secwatch.observer/filing/0000920148-26-000205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer